he critical role of neuroimmune interactions in atopic dermatitis and prurigo nodularis, focusing on how targeted IL-31 treatment can improve patient outcomes.

Galderma will also present four e-posters on AKLIEF (trifarotene) cream, showcasing decades of innovation behind four generations of retinoids, including fourth-generation trifarotene, its role in acne and skin health, and its molecular design.7,8 Real-world data will further evaluate its impact on acne outcomes and skin quality through personalized regimens and assess its efficacy and safety for facial and truncal acne in Indian patients.5,6

Dermatological Skincare: Nine presentations spanning sensitive skin, acne, eczema-prone and mature skin

Two oral presentations will be delivered at the congress: one exploring how high-risk factors for sensitive skin can be identified through artificial intelligence (Saturday March 28 at 1:05-1:10 PM MDT / 8:05-8:10 PM CET in Lobby C, Poster Center 2), and another to share resul
=*=*=*=*=*=
当前为第5/17页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页